MedTrace Logo

Anti-inflammatory Effects of Tiotropium in Patients with Stable COPD

NCT04061161 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2024-09-25

No results posted yet for this study

Summary

This study aims to assess the anti-inflammatory effects after 6 weeks treatment with tiotropium compared to placebo in patients with stable COPD

Conditions

Interventions

DRUG

Tiotropium Bromide

Participants will be double-blind randomized for Tiotropium or Placebo treatment for 6 weeks

Sponsors & Collaborators

Principal Investigators

  • Wouter van Geffen, MD PhD · Medical centrum Leeuwarden, Department of pulmonology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-19
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04061161 on ClinicalTrials.gov